These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 2387550)

  • 21. MELD score and blood product requirements during liver transplantation: no link.
    Massicotte L; Beaulieu D; Roy JD; Marleau D; Vandenbroucke F; Dagenais M; Lapointe R; Roy A
    Transplantation; 2009 Jun; 87(11):1689-94. PubMed ID: 19502961
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intraoperative blood transfusion requirement is the main determinant of early surgical re-intervention after orthotopic liver transplantation.
    Hendriks HG; van der Meer J; de Wolf JT; Peeters PM; Porte RJ; de Jong K; Lip H; Post WJ; Slooff MJ
    Transpl Int; 2005 Jan; 17(11):673-9. PubMed ID: 15717214
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Advantages of haemotherapy with blood components in heart surgery with estracorporeal circulation (author's transl)].
    Barbolla L; Fernández N; Alvarez L; Agosti J
    Sangre (Barc); 1978; 23(5):513-20. PubMed ID: 741337
    [No Abstract]   [Full Text] [Related]  

  • 24. Early postoperative hemorrhage requiring urgent surgical reintervention after orthotopic liver transplantation.
    Liang TB; Bai XL; Li DL; Li JJ; Zheng SS
    Transplant Proc; 2007 Jun; 39(5):1549-53. PubMed ID: 17580186
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Disorders of hemostasis in liver cirrhosis. 2. Therapy].
    Neidhardt B; Schricker KT
    Fortschr Med; 1982 May; 100(18):836-40. PubMed ID: 6178666
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment with AT III concentrates in hereditary and acquired AT III deficiency.
    Gromnica-Ihle E; Ziemer S
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(3):307-13. PubMed ID: 2465221
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Coagulation defects do not predict blood product requirements during liver transplantation.
    Massicotte L; Beaulieu D; Thibeault L; Roy JD; Marleau D; Lapointe R; Roy A
    Transplantation; 2008 Apr; 85(7):956-62. PubMed ID: 18408574
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Autotransfusion in cardiac surgery. Value of red blood cell washing in operations with high hemorrhagic risk].
    Chauvaud S; Massonnet-Castel S; Pelissier E; Fabiani JN; Abry B; Carpentier A
    Ann Chir; 1987; 41(6):421-5. PubMed ID: 3674704
    [No Abstract]   [Full Text] [Related]  

  • 29. An algorithmic approach to coagulation testing.
    Klein K; Hartman SK; Teruya J; Hui SK
    Dis Mon; 2012 Aug; 58(8):431-9. PubMed ID: 22818557
    [No Abstract]   [Full Text] [Related]  

  • 30. Advantages of venous bypass during orthotopic transplantation of the liver.
    Shaw BW; Martin DJ; Marquez JM; Kang YG; Bugbee AC; Iwatsuki S; Griffith BP; Hardesty RL; Bahnson HT; Starzl TE
    Semin Liver Dis; 1985 Nov; 5(4):344-8. PubMed ID: 3909428
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The impact of intraoperative transfusion of platelets and red blood cells on survival after liver transplantation.
    de Boer MT; Christensen MC; Asmussen M; van der Hilst CS; Hendriks HG; Slooff MJ; Porte RJ
    Anesth Analg; 2008 Jan; 106(1):32-44, table of contents. PubMed ID: 18165548
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Changes in hemostasis during orthotopic liver transplantation and massive transfusion: a case report].
    Kozek-Langenecker SA; Müller CM; Felfernig M; Zimpfer M
    Infusionsther Transfusionsmed; 1995 Oct; 22(5):296-300. PubMed ID: 8924744
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Abnormalities of plasma von Willebrand factor multimeric structure induced by extracorporeal circulation.
    Perutelli P; Lerzo F; Calza G; Cevasco M; Mori PG
    Haematologica; 1999 Mar; 84(3):287-8. PubMed ID: 10189403
    [No Abstract]   [Full Text] [Related]  

  • 34. Migration of transjugular intrahepatic portosystemic shunt to the right atrium: complications in the intraoperative period of liver transplantation.
    da Silva RF; Arroyo PC; Duca WJ; da Silva AA; Reis LF; Miquelin DG; Sgnolf A; Cabral CM; Ayres DC; de Lima AP; da Silva RC
    Transplant Proc; 2008 Dec; 40(10):3778-80. PubMed ID: 19100488
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Use of antithrombin III concentrates].
    Vinazzer H
    Beitr Infusionsther; 1989; 24():151-8. PubMed ID: 2481532
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antithrombin III. Key factor in extracorporeal circulation.
    Ranucci M
    Minerva Anestesiol; 2002 May; 68(5):454-7. PubMed ID: 12029263
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The system of hemostasis in experimental liver transplantation].
    Zhidkov IL; Michailov IE; Broun NK; Smirnova LA; Buianov VV; Eramishantsev AK
    Khirurgiia (Mosk); 1997; (2):35-8. PubMed ID: 9162767
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Severe intraoperative hyperglycemia is independently associated with surgical site infection after liver transplantation.
    Park C; Hsu C; Neelakanta G; Nourmand H; Braunfeld M; Wray C; Steadman RH; Hu KQ; Cheng RT; Xia VW
    Transplantation; 2009 Apr; 87(7):1031-6. PubMed ID: 19352123
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antithrombin III supplementation during orthotopic liver transplantation in cirrhotic patients: a randomized trial.
    Baudo F; DeGasperi A; deCataldo F; Caimi TM; Cattaneo D; Redaelli R; Pannacciulli E; Corti A; Mazza E; Belli L
    Thromb Res; 1992 Dec; 68(4-5):409-16. PubMed ID: 1290169
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Experiences with the substitution of antithrombin III concentrates in congenital and acquired deficiency disorders].
    Schramm W
    Behring Inst Mitt; 1983 Aug; (73):66-78. PubMed ID: 6332613
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.